ライフサイエンスコーパス: carotid artery stenting

1 rization subtypes (carotid endarterectomy vs carotid artery stenting).

2 platelet therapy, carotid endarterectomy and carotid artery stenting.

3 ion and 6640 patients underwent transfemoral carotid artery stenting.

4 dical treatment, carotid endarterectomy, and carotid artery stenting.

5 endarterectomy, and may be safely treated by carotid artery stenting.

6 m procedure choices for patients considering carotid artery stenting.

7 tid artery revascularization vs transfemoral carotid artery stenting.

8 lic Protection System in patients undergoing carotid artery stenting.

9 Carotid endarterectomy and carotid artery stenting.

10 ata outside of controlled clinical trials in carotid artery stenting.

11 lirudin and unfractionated heparin (UFH) for carotid artery stenting.

12 ith UFH during the index hospitalization for carotid artery stenting.

13 re for long-term mortality in patients after carotid artery stenting.

14 ensively investigated in patients undergoing carotid artery stenting.

15 to 2 years after carotid endarterectomy and carotid artery stenting.

16 darterectomy (2.26, 1.34-3.77) but not after carotid artery stenting (0.77, 0.41-1.42).

17 d had eligible ultrasonography (1086 who had carotid artery stenting, 1105 who had carotid endarterec

18 1036 patients (536 randomly allocated to carotid artery stenting, 500 to carotid endarterectomy)

19 Two independent cohorts after successful carotid artery stenting (602 and 552 patients) were pros

20 An additional 8 carotid artery stenting and 12 carotid endarterectomy pa

21 Among 2502 patients, 14 MIs occurred in carotid artery stenting and 28 MIs in carotid endarterec

22 (CREST) found a higher risk of stroke after carotid artery stenting and a higher risk of myocardial

23 ral stroke thereafter did not differ between carotid artery stenting and carotid endarterectomy for s

24 the primary endpoint did not differ between carotid artery stenting and carotid endarterectomy in pa

25 l data comparing carotid endarterectomy with carotid artery stenting and describe ischemic visual sym

26 Carotid-artery stenting and carotid endarterectomy are b

27 differ significantly in the group undergoing carotid-artery stenting and the group undergoing carotid

28 Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call

29 Carotid endarterectomy and carotid artery stenting are the leading approaches to re

30 er, its outcomes, compared with transfemoral carotid artery stenting, are not well characterized.

31 lopidogrel and Atorvastatin Treatment During Carotid Artery Stenting [ARMYDA-9 CAROTID]; NCT01572623)

32 patients in the CARE Registry who underwent carotid artery stenting between May 2005 and March 2012

33 randomized to carotid endarterectomy versus carotid artery stenting, both MI and biomarker+ only wer

34 modynamic depression has been reported after carotid artery stenting CAS and carotid endarterectomy (

35 lict regarding the relative effectiveness of carotid artery stenting (CAS) and carotid artery endarte

36 epresentative 30-day readmissions data after carotid artery stenting (CAS) and carotid endarterectomy

37 four randomised controlled trials comparing carotid artery stenting (CAS) and carotid endarterectomy

38 ncreased risk of periprocedural stroke after carotid artery stenting (CAS) compared with carotid enda

39 Despite increased carotid artery stenting (CAS) dissemination following th

40 Carotid artery stenting (CAS) has achieved clinical equi

41 Carotid artery stenting (CAS) has become an alternative

42 Significant advances in the field of carotid artery stenting (CAS) have occurred, including n

43 ought to evaluate the safety and efficacy of carotid artery stenting (CAS) in high risk patients.

44 y was to evaluate the safety and efficacy of carotid artery stenting (CAS) in high-risk patients.

45 ding whether carotid endarterectomy (CEA) or carotid artery stenting (CAS) may be superior for stroke

46 h following carotid endarterectomy (CEA) and carotid artery stenting (CAS) on a national level in Ger

47 roke or transient cerebral ischaemia, either carotid artery stenting (CAS) or carotid endarterectomy

48 ports periprocedural outcomes in a cohort of carotid artery stenting (CAS) performed for asymptomatic

49 ndarterectomy (CEA) plus medical therapy, or carotid artery stenting (CAS) plus medical therapy for a

50 Effectiveness of carotid artery stenting (CAS) relative to carotid endart

51 Clinical trials demonstrated the efficacy of carotid artery stenting (CAS) relative to carotid endart

52 riprocedural stroke or death is higher after carotid artery stenting (CAS) than carotid endarterectom

53 dicaid Services require hospitals performing carotid artery stenting (CAS) to recertify the quality o

54 fe (HRQOL) outcomes in patients treated with carotid artery stenting (CAS) versus carotid endarterect

55 esigned to assess the safety and efficacy of carotid artery stenting (CAS) when performed by physicia

56 as to evaluate the feasibility and safety of carotid artery stenting (CAS) with a filter protection s

57 ted imaging (DWI) are frequently found after carotid artery stenting (CAS), but their clinical releva

58 ts following carotid endarterectomy (CEA) or carotid artery stenting (CAS), the applicability of thes

59 quences of hemodynamic depression (HD) after carotid artery stenting (CAS).

60 risk factors for their development following carotid artery stenting (CAS).

61 utcome after carotid endarterectomy (CEA) or carotid artery stenting (CAS).

62 (CEA) and is traditionally an indication for carotid artery stenting (CAS).

63 A recent alternative is carotid artery stenting (CAS).

64 to predict in-hospital stroke or death after carotid artery stenting (CAS).

65 -protected versus proximal balloon-protected carotid artery stenting (CAS).

66 undergoing carotid endarterectomy (CEA) and carotid artery stenting (CAS); to describe hospital vari

67 1.41) and 31 (6.8%) of 455 women assigned to carotid artery stenting compared with 16 (3.8%) of 417 a

68 occurred in 35 (4.3%) of 807 men assigned to carotid artery stenting compared with 40 (4.9%) of 823 a

69 perioperative stroke following transfemoral carotid artery stenting compared with carotid endarterec

70 Rates of the primary endpoint for carotid artery stenting compared with carotid endarterec

71 ow-up is needed to establish the efficacy of carotid artery stenting compared with endarterectomy.

72 ural intervention (carotid endarterectomy or carotid artery stenting) compared with medical managemen

73 Carotid artery stenting, compared with carotid endartere

74 This study sought to report the effect of carotid artery stenting (CS) on neurocognitive function

75 Of 1021 patients treated with carotid artery stenting during a mean follow-up of 3.1+/

76 id artery revascularization and transfemoral carotid artery stenting for carotid artery stenosis, fro

77 ion in the left eye improved to 30/100 after carotid artery stenting for the left common carotid arte

78 Carotid artery stenting has been limited to use in patie

79 Participants in PMS studies for carotid artery stenting have different clinical and proc

80 g-term effectiveness in stroke prevention by carotid artery stenting in a large number of patients in

81 The role of carotid artery stenting in acute stroke, including its u

82 ed from controlled clinical trials undergoes carotid artery stenting in daily clinical practice.

83 ggest that independent modular filter use in carotid artery stenting in high surgical risk patients i

84 nrandomized, open-label, single-arm study of carotid artery stenting in high surgical risk patients w

85 To evaluate outcomes after carotid artery stenting in larger real-world populations

86 es, and subsequent all-cause mortality after carotid artery stenting in PMS study participants and no

87 Whether PMS studies are representative of carotid artery stenting in routine clinical practice has

88 eview outcomes of carotid endarterectomy and carotid artery stenting in women, discuss differences in

89 rom 1999 to 2014, whereas the performance of carotid artery stenting increased until 2006 and then de

90 Carotid artery stenting is an alternative option in pati

91 Long-term stroke prevention by carotid artery stenting is effective in experienced cent

92 Carotid artery stenting is feasible, can be performed ev

93 r, the role of direct thrombin inhibitors in carotid artery stenting is not well defined.

94 In 2 years, 58 patients who underwent carotid artery stenting (Kaplan-Meier rate 6.0%) and 62

95 Carotid artery stenting may be a reasonable alternative,

96 75.8 years; 43% women) and 231077 underwent carotid artery stenting (mean age, 75.4 years; 49% women

97 signed to carotid endarterectomy (n=1240) or carotid artery stenting (n=1262), 872 (34.9%) of whom we

98 th symptomatic carotid stenosis treated with carotid artery stenting (n=2326) or carotid endarterecto

99 carotid artery stenosis randomly assigned to carotid artery stenting or carotid endarterectomy (Abbot

100 dy (ICSS) were randomly allocated to receive carotid artery stenting or carotid endarterectomy.

101 randomly assigned in a 1:1 ratio to receive carotid artery stenting or carotid endarterectomy.

102 or asymptomatic carotid stenosis to undergo carotid-artery stenting or carotid endarterectomy.

103 rocedural stroke or death risk compared with carotid artery stenting patients, and the difference sig

104 anagement alone (medical-therapy group) with carotid-artery stenting plus intensive medical managemen

105 ient-specific simulated rehearsal (PsR) of a carotid artery stenting procedure (CAS) enables the inte

106 Embolic protection during carotid artery stenting reduces the rate of thromboembol

107 Carotid artery stenting should be avoided in patients wi

108 arotid endarterectomy (CEA) and transfemoral carotid artery stenting (TF-CAS) for high-risk patients

109 CAR) compared with percutaneous transfemoral carotid artery stenting (TF-CAS) for stroke prevention b

110 arotid endarterectomy (CEA) and transfemoral carotid artery stenting (TFCAS).

111 ve shown a higher early risk of stroke after carotid artery stenting than after carotid endarterectom

112 Stroke occurs more commonly after carotid artery stenting than after carotid endarterectom

113 events seems to be higher in women who have carotid artery stenting than those who have carotid enda

114 In patients treated with carotid artery stenting, those with an ARWMC score of 7

115 Extrapolating results from PMS studies of carotid artery stenting to larger real-world settings sh

116 reas no significant decrease was found after carotid artery stenting (unadjusted odds ratio, 0.96; 95

117 tive risk of stroke in patients treated with carotid artery stenting versus carotid endarterectomy.

118 gnificantly lower stroke rates compared with carotid artery stenting via the transfemoral approach.

119 Carotid artery stenting was associated with a higher ris

120 .02 to 2.61]; P = .04), whereas transfemoral carotid artery stenting was associated with more radiati

121 Carotid artery stenting was performed with the Protege S

122 evascularization, compared with transfemoral carotid artery stenting, was significantly associated wi

123 Both carotid endarterectomy and carotid artery stenting were equally effective in reduci

124 tid artery revascularization or transfemoral carotid artery stenting were identified (transcarotid ap

125 of this study was to determine the safety of carotid artery stenting with a unique distal embolic pro

126 term outcomes between patients who underwent carotid artery stenting with an emboli-protection device

127 gh-risk features for carotid endarterectomy, carotid artery stenting with distal embolic protection i

128 (Carotid Artery Stenting With Emboli Protection Surveilla

129 The CASES-PMS (Carotid Artery Stenting With Emboli Protection Surveilla

130 Carotid artery stenting with filter protection is techni

131 We compared the safety of carotid artery stenting with that of carotid endarterect

132 The trial evaluated carotid artery stenting with the use of an emboli-protec

133 Previous clinical trials have suggested that carotid-artery stenting with a device to capture and rem

134 in 20 patients randomly assigned to undergo carotid-artery stenting with an emboli-protection device

135 In this trial, we compared carotid-artery stenting with embolic protection and caro

136 We conducted a randomized trial comparing carotid-artery stenting with the use of an emboli-protec